Full View

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

P Wallemacq, V VanKerckhove, L Elens… - American journal of …, 2006 - Wiley Online Library
Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G> A, CYP3A5* 3;
14690A> G, CYP3A5* 6) and drug transporter ABCB1 (1236C> T; 2677G> T/A; 3435C> T) …
被引用次数：225 相关文章

CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study

V Haufroid, P Wallemacq, V Vankerckhove… - American Journal of …, 2006 - hero.epa.gov
Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G> A, CYP3A5* 3;
14690A> G, CYP3A5* 6) and drug transporter ABCB1 (1236C> T; 2677G> T/A; 3435C> T) …

[引用][C] CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: Guidelines from an experimental study

V HAUFROID, P WALLEMACQ… - American journal of …, 2006 - pascal-francis.inist.fr
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant
candidates : Guidelines from an experimental study CNRS Inist Pascal-Francis CNRS …
[HTML] amjtransplant.org

[HTML][HTML] CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

V Haufroid, P Wallemacq… - American Journal of …, 2006 - amjtransplant.org
Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G> A, CYP3A5* 3;
14690A> G, CYP3A5* 6) and drug transporter ABCB1 (1236C> T; 2677G> T/A; 3435C> T) …
[HTML] sciencedirect.com

[HTML][HTML] CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

V Haufroid, P Wallemacq, V VanKerckhove… - American Journal of …, 2006 - Elsevier
Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G> A, CYP3A5* 3;
14690A> G, CYP3A5* 6) and drug transporter ABCB1 (1236C> T; 2677G> T/A; 3435C> T) …

[引用][C] CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

V Haufroid, P Wallemacq, V VanKerckhove… - American Journal of …, 2006 - cir.nii.ac.jp
CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant
Candidates: Guidelines from an Experimental Study | CiNii Research CiNii 国立情報学研究所 …
[PDF] saintluc.be

[PDF][PDF] CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

V Haufroida, P Wallemacqb, V VanKerckhovea… - American Journal of …, 2006 - saintluc.be
Tacrolimus (Tac, FK506) is widely used to prevent acute rejection following solid-organ
transplantation. Like cyclosporin (CsA), this drug is characterized by a narrow therapeutic …
[PDF] saintluc.be

[PDF][PDF] CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

V Haufroida, P Wallemacqb, V VanKerckhovea… - American Journal of …, 2006 - saintluc.be
Tacrolimus (Tac, FK506) is widely used to prevent acute rejection following solid-organ
transplantation. Like cyclosporin (CsA), this drug is characterized by a narrow therapeutic …

CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study.

V Haufroid, M De Meyer, P Wallemacq… - American journal of …, 2006 - dial.uclouvain.be
Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G> A, CYP3A5* 3;
14690A> G, CYP3A5* 6) and drug transporter ABCB1 (1236C> T; 2677G> T/A; 3435C> T) …

CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study.

V Haufroid, P Wallemacq, V VanKerckhove… - American Journal of …, 2006 - europepmc.org
Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G> A, CYP3A5* 3;
14690A> G, CYP3A5* 6) and drug transporter ABCB1 (1236C> T; 2677G> T/A; 3435C> T) …